Key Highlights
•
A new study published in *CA: A Cancer Journal for Clinicians* shows that adding the chemotherapy drug temozolomide after radiotherapy significantly improves survival for patients with a specific type of aggressive brain tumor called IDH-mutated anaplastic glioma.
Source →
•
This finding offers a new and more effective standard treatment option for patients with this challenging type of brain cancer, potentially changing clinical practice and improving long-term outcomes.
Source →
•
Research in *Cell Death & Disease* reveals that a protein called SEL1L3 can stop colorectal cancer from growing and spreading by protecting another protein, STING, from being broken down inside cells.
Source →
•
This discovery identifies a potential new target for drugs that could treat colorectal cancer by harnessing the body’s own immune defenses, offering a new avenue for therapy development.
Source →
•
A large study from Scotland published in the *European Heart Journal* found that people over 50 with heart failure have a slightly higher risk of developing cancer, and those who have both conditions face a very high death rate—around 15-28% each year—from either heart disease or cancer.
Source →
•
This finding highlights the critical, often overlooked link between heart disease and cancer, underscoring the need for doctors to monitor cancer patients for heart failure and vice versa to provide more integrated care.
Source →
•
A correction published in *Annals of Surgical Oncology* re-evaluates the risk of cancer recurrence after using the immunotherapy drug nivolumab following surgery for advanced esophageal cancer, providing more accurate data for patients and clinicians.
Source →
•
This corrected information is crucial for surgeons and oncologists as it refines the understanding of which patients benefit most from this powerful immunotherapy after surgery, helping to avoid unnecessary treatment side effects.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
